Literature DB >> 18457724

[Cutaneous leishmaniasis due to Leishmania major involving the bone marrow in an AIDS patient in Burkina Faso].

F Barro-Traoré1, L Preney, A Traoré, H Darie, P Tapsoba, A Bassolé, S Sawadogo, P Niamba, E Grosshans, M Geniaux.   

Abstract

BACKGROUND: Leishmaniasis covers three well-individualized clinical variants, each due to individual species found in different geographic areas. Herein we report the first case of cutaneous leishmaniasis due to Leishmania major involving bone marrow in an AIDS patient in Burkina Faso. CASE REPORT: A 38-year-old HIV-positive man presented with generalized, copper-coloured, painless, infiltrated, itching, papulonodular lesions present over the previous 10 months. Skin biopsy confirmed the diagnosis of diffuse cutaneous leishmaniasis. The bone-marrow smear showed numerous leishmania. The culture was positive and L. major was identified. The patient was being treated with antiretroviral medication and a pentavalent antimonial compound. The disease progression consisted of attacks and remissions separated by an average of three weeks. DISCUSSION: L. major is the Leishmania species identified in Burkina Faso. It is responsible for typical cutaneous leishmaniasis but particular clinical forms have been described in immunodeficient patients, especially with diffuse cutaneous involvement. The spread of L. major infection to bone marrow could represent a public health problem in our country, where the HIV epidemic is still not under control, and particular vigilance is thus called for.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18457724     DOI: 10.1016/j.annder.2007.10.005

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  7 in total

1.  Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia.

Authors:  Tesfaye Gelanew; Zewdu Hurissa; Ermias Diro; Aysheshm Kassahun; Katrin Kuhls; Gabriele Schönian; Asrat Hailu
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  A patient presenting with diffuse cutaneous leishmaniasis (DCL) as a first indicator of HIV infection in India.

Authors:  Kanika Khandelwal; Ram Awatar Bumb; Rajesh Dutt Mehta; Himanshu Kaushal; Claudio Lezama-Davila; Poonam Salotra; Abhay R Satoskar
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

Review 3.  PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.

Authors:  Eduard E Zijlstra
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

4.  Epidemiological profile of cutaneous leishmaniasis: retrospective analysis of 7444 cases reported from 1999 to 2005 at Ouagadougou, Burkina Faso.

Authors:  Sanata Bamba; Alphonse Gouba; Maxime Koiné Drabo; Désiré Nezien; Mamadou Bougoum; Tinga Robert Guiguemdé
Journal:  Pan Afr Med J       Date:  2013-03-19

5.  Leishmania major infection in humanized mice induces systemic infection and provokes a nonprotective human immune response.

Authors:  Anja Kathrin Wege; Christian Florian; Wolfgang Ernst; Nicole Zimara; Ulrike Schleicher; Frank Hanses; Maximilian Schmid; Uwe Ritter
Journal:  PLoS Negl Trop Dis       Date:  2012-07-24

6.  First Serological Study Revealing High Humoral Response and Evidence for Antigenic Heterogeneity in Leishmania donovani Induced CL in Sri Lanka.

Authors:  Bhagya Deepachandi; Sudath Weerasinghe; Samantha Ranasinghe; Thisira P Andrahennadi; Mahendra N Wickramanayake; Shantha Siri; Nadira Karunaweera; Vishvanath Chandrasekharan; Mitali Chatterjee; Preethi Soysa; Yamuna Siriwardana
Journal:  Biomed Res Int       Date:  2020-09-29       Impact factor: 3.411

7.  Persistent Cutaneous Leishmania major Infection Promotes Infection-Adapted Myelopoiesis.

Authors:  Fabio Luiz Bandeira Ferreira; Olivier Séguin; Albert Descoteaux; Krista M Heinonen
Journal:  Microorganisms       Date:  2022-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.